Geneva Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | $326K | Buy |
+2,528
| New | +$326K | 0.01% | 593 |
|
|
2016
Q4 | – | Sell |
-8,415
| Closed | -$734K | – | 811 |
|
|
2016
Q3 | $734K | Sell |
8,415
-8,040
| -49% | -$701K | 0.01% | 387 |
|
|
2016
Q2 | $1.42M | Buy |
16,455
+13,852
| +532% | +$1.19M | 0.03% | 243 |
|
|
2016
Q1 | $207K | Buy |
+2,603
| New | +$207K | ﹤0.01% | 605 |
|
|
2015
Q3 | – | Sell |
-4,507
| Closed | -$557K | – | 687 |
|
|
2015
Q2 | $557K | Sell |
4,507
-94,774
| -95% | -$11.7M | 0.01% | 409 |
|
|
2015
Q1 | $11.7M | Buy |
+99,281
| New | +$11.7M | 0.21% | 91 |
|